Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Nutex Health (NUTX) Research & Development (2019 - 2022)

Historic Research & Development for Nutex Health (NUTX) over the last 4 years, with Q1 2022 value amounting to $73750.0.

  • Nutex Health's Research & Development fell 387.12% to $73750.0 in Q1 2022 from the same period last year, while for Mar 2022 it was $282910.0, marking a year-over-year decrease of 4549.97%. This contributed to the annual value of $285880.0 for FY2021, which is 4869.87% down from last year.
  • Latest data reveals that Nutex Health reported Research & Development of $73750.0 as of Q1 2022, which was down 387.12% from $77265.0 recorded in Q4 2021.
  • Nutex Health's Research & Development's 5-year high stood at $314255.0 during Q2 2020, with a 5-year trough of $54296.0 in Q4 2020.
  • Over the past 4 years, Nutex Health's median Research & Development value was $77265.0 (recorded in 2021), while the average stood at $129614.6.
  • Examining YoY changes over the last 5 years, Nutex Health's Research & Development showed a top increase of 4230.33% in 2021 and a maximum decrease of 8102.53% in 2021.
  • Quarter analysis of 4 years shows Nutex Health's Research & Development stood at $196632.0 in 2019, then plummeted by 72.39% to $54296.0 in 2020, then surged by 42.3% to $77265.0 in 2021, then dropped by 4.55% to $73750.0 in 2022.
  • Its Research & Development was $73750.0 in Q1 2022, compared to $77265.0 in Q4 2021 and $72266.0 in Q3 2021.